Transformative therapies for myotonic dystrophy
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center
This study is working on new treatments for myotonic dystrophy types 1 and 2 by teaming up scientists and doctors to better understand the disease and help improve care for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-10992312 on NIH RePORTER |
What this research studies
This research focuses on developing innovative treatments for myotonic dystrophy type 1 (DM1) and type 2 (DM2) through a collaborative effort between basic scientists and clinical researchers. The Wellstone Center will utilize advanced mouse models to study the disease mechanisms and support clinical trials aimed at improving patient outcomes. By investigating the genetic and molecular characteristics of DM1 and DM2, the research aims to accelerate the transition from laboratory findings to effective therapies for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals aged 21 and older who have been diagnosed with myotonic dystrophy type 1 or type 2.
Not a fit: Patients with other forms of muscular dystrophy or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking therapies that significantly improve the quality of life for individuals affected by myotonic dystrophy.
How similar studies have performed: Previous research has shown promising results in developing therapies for myotonic dystrophy, indicating that this approach has the potential for success.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Swanson, Maurice Scott — University of Florida
- Study coordinator: Swanson, Maurice Scott
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.